| Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632) |
|---|
| 03/30/2006 | WO2006033791A1 Multiple-biosensor article |
| 03/30/2006 | WO2006033742A2 Engineered antibody fragment that irreversibly binds an antigen |
| 03/30/2006 | WO2006033733A1 Bodily fluid analysis system |
| 03/30/2006 | WO2006033732A1 Synthesis of highly luminescent colloidal particles |
| 03/30/2006 | WO2006033675A2 Bacillus anthracis spore specific antobodies |
| 03/30/2006 | WO2006033665A1 Tat-based vaccine compositions and methods of making and using same |
| 03/30/2006 | WO2006033662A2 Methods and kits for detection of multiple pathogens |
| 03/30/2006 | WO2006033484A1 Nucleic acid microarray and nucleic acid probe designing method, and method of gene detection |
| 03/30/2006 | WO2006033413A1 Method of quantifying peptide |
| 03/30/2006 | WO2006033409A1 Method of assaying anti-hcv agent with use of cyclophilin |
| 03/30/2006 | WO2006033387A1 Method of detecting gene governing allergic predisposition |
| 03/30/2006 | WO2006033368A1 METHOD OF DETECTING HEPATITIS B VIRUS s ANTIGEN |
| 03/30/2006 | WO2006033348A1 Labeling enzyme |
| 03/30/2006 | WO2006033130A2 Rapid monitoring system for blood groups and immunohematological reaction detection |
| 03/30/2006 | WO2006033102A1 A system and method for three-dimensional location of inclusions in a gemstone |
| 03/30/2006 | WO2006032926A2 Improvements in high content screening |
| 03/30/2006 | WO2006032912A1 Treatment of spongiform encephalopathy by increased hydrogen peroxide degradation |
| 03/30/2006 | WO2006032905A1 Treatment of atherosclerosis |
| 03/30/2006 | WO2006032859A2 Treatment of schizophrenia or suicidal behaviour with a 5-ht2c receptor antagonist |
| 03/30/2006 | WO2006032809A2 Method for detecting streptococcus agalactiae using esterase activity |
| 03/30/2006 | WO2006032719A1 Supported-phase indicator system for the detection of sulphurated compounds of the mercaptan type and other molecules with thiol groups that produce unpleasant odours |
| 03/30/2006 | WO2006032704A2 Diagnostic compounds for targeting a chemokine receptor |
| 03/30/2006 | WO2006032419A1 Use of perfluoropolymer submicrometric latexes in the determination of molecular interactions by laser light scattering (lls) |
| 03/30/2006 | WO2006032392A2 Uses of carbamoyl phosphate synthetase 1 (cps 1) as a humoral biomarker for the diagnosis of tumour diseases and chronic inflammatory intestinal diseases |
| 03/30/2006 | WO2006032330A1 Annexin modulation and resistance to infection |
| 03/30/2006 | WO2006032158A1 Electrochemical patterning on multi-channel microelectrode array for biosensing applications |
| 03/30/2006 | WO2006032127A1 Cytotoxicity mediation of cells evidencing surface expression of mcsp |
| 03/30/2006 | WO2006032126A1 Diagnosis and treatment of early pre-type-1 diabetes utilizing neuronal proteins |
| 03/30/2006 | WO2006013016A3 Diagnostics and therapeutics for diseases associated with eosinophil serine protease 1 (prss21) |
| 03/30/2006 | WO2006013015A3 Diagnostics and therapeutics for diseases associated with marapsin (mpn) |
| 03/30/2006 | WO2006013014A3 Diagnostics and therapeutics for diseases associated with prostate-specific membrane antigen-like protein (psmal) |
| 03/30/2006 | WO2006012451A3 Compositions and methods of use for mgd-csf in disease treatment |
| 03/30/2006 | WO2006008142A8 Diagnosis and therapy of psoriasis vulgaris |
| 03/30/2006 | WO2006008126A3 Novel use of the kinases rsk4 and pak5 |
| 03/30/2006 | WO2006008005A3 Diagnostics and therapeutics for diseases associated with hepatocyte nuclear factor 2 (hzf2) |
| 03/30/2006 | WO2006005460A3 Diagnostics and therapeutics for diseases associated with nuclear receptor subfamily 2, group e, member 1 (nr2e1) |
| 03/30/2006 | WO2005123048A3 Screening methods using c-abl, fyn and syk in combination with tau protein |
| 03/30/2006 | WO2005122022A3 Method for identifying sub-sequences of interest in a sequence |
| 03/30/2006 | WO2005117994A9 Bmp pathway methods and compositions |
| 03/30/2006 | WO2005116648A3 Method and reagent kit for evaluation of multidrug-resistance activity |
| 03/30/2006 | WO2005116265A3 Probe arrays for expression profiling of rat genes |
| 03/30/2006 | WO2005113764A3 Modulation of wrn-mediated telomere-initiated cell signaling |
| 03/30/2006 | WO2005108614A3 Reversible and chemically programmable micelle assembly with dna block-copolymer amphiphiles |
| 03/30/2006 | WO2005105838A3 Ion channel |
| 03/30/2006 | WO2005103710A3 Diagnostics and therapeutics for diseases associated with corticotropin releasing hormone receptor 1 (crhr1) |
| 03/30/2006 | WO2005101010A3 Diagnostics and therapeutics for diseases associated with peroxisome proliferator activated receptor gamma (pparg) |
| 03/30/2006 | WO2005098435A3 Peptides and peptidomimetics binding to cd23 |
| 03/30/2006 | WO2005095956A3 Diagnostics and therapeutics for diseases associated with megakaryocyte-associated tyrosine-protein kinase |
| 03/30/2006 | WO2005091200A3 Method for determining real molecular masses for biological sample constituents |
| 03/30/2006 | WO2005090995A3 Method for the detection of autoantibodies against specific peptides and its use in diagnosis and treatment of pregnancy-loss or infertility |
| 03/30/2006 | WO2005083434A3 Device and method for the optical evaluation of test strips |
| 03/30/2006 | WO2005081707A3 Methodology and apparatus for the detection of biological substances |
| 03/30/2006 | WO2005072112A3 Methods for producing and identifying multispecific antibodies |
| 03/30/2006 | WO2005068612A3 Human hepatic progenitor cells and methods of use thereof |
| 03/30/2006 | WO2005057174A3 Method and apparatus for low blood glucose level detection |
| 03/30/2006 | WO2005047899A3 Use of the lipoxin receptor, fprl1, as a tool for identifying compounds effective in the treatment of pain and inflammation |
| 03/30/2006 | WO2005047546A3 Diagnostic and prognostic methods and compositions for seizure- and plasticity-related disorders |
| 03/30/2006 | WO2005046573A3 Pro104 antibody compositions and methods of use |
| 03/30/2006 | WO2005031305A3 Surface immobilized polyelectrolyte with multiple functional groups capable of covalently bonding to biomolecules |
| 03/30/2006 | WO2005026380A3 Bone marrow proliferation assay |
| 03/30/2006 | WO2005015209A3 Methods and systems for the annotation of biomolecule patterns in chromatography/mass-spectrometry analysis |
| 03/30/2006 | WO2004096199A3 Regulation of guanine nucleotide exchange factor |
| 03/30/2006 | WO2004094458A3 Major histocompatibility complex (mhc)-peptide arrays |
| 03/30/2006 | WO2004072103A3 Macromolecule identification made by mass spectrometry and database searching |
| 03/30/2006 | WO2004070012A3 Cell-killing molecules and methods of use thereof |
| 03/30/2006 | WO2004065932A3 Methods of identifying modulators of cellular glycosylation using gtrap3-18 |
| 03/30/2006 | WO2004063714A3 Methods for the detection, analysis and isolation of nascent proteins |
| 03/30/2006 | WO2004053071A3 Method for discovering neurogenic agents |
| 03/30/2006 | WO2004033626A3 Hyperglycosylated hcg (invasive trophoblast antigen) in differential diagnosis of malignant or invasive trophoblastic disease |
| 03/30/2006 | WO2003105783A3 Cancer-linked gene as target for chemotherapy |
| 03/30/2006 | WO2003062369A3 Expansion of renewable stem cell populations |
| 03/30/2006 | WO2003014294A3 Tacis and br3 polypeptides and uses thereof |
| 03/30/2006 | US20060070136 GLYT1 transgenic mouse |
| 03/30/2006 | US20060070134 Diagnosis and treatment of fanconi's anemia |
| 03/30/2006 | US20060069717 Security service for a services oriented architecture in a data integration platform |
| 03/30/2006 | US20060069519 Method for predicting protein-protein interactions |
| 03/30/2006 | US20060069510 Method and system for measuring depth to saturated soils |
| 03/30/2006 | US20060069245 Screening methods for cognitive enhancers |
| 03/30/2006 | US20060069242 Neurotrophic factor receptor |
| 03/30/2006 | US20060069025 Survivin, a protein that inhibits cellular apoptosis, and its modulation |
| 03/30/2006 | US20060069014 Inhibition of histone deacetylase as a treatment for cardiac hypertrophy |
| 03/30/2006 | US20060068506 Field of modular multifunctional ligands |
| 03/30/2006 | US20060068505 Biopolymer marker indicative of disease state having a molecular weight of 1077 daltons |
| 03/30/2006 | US20060068504 Functional particle array and method of use thereof |
| 03/30/2006 | US20060068503 Solid support membranes for ion channel arrays and sensors: application ro rapid screening of pharmacological compounds |
| 03/30/2006 | US20060068502 Method for determining the presence of an analyte; providing in a single molecule: a molecular scaffold, a first label an RET donor and a second label of an RET acceptor bound to the molecular scaffold, a molecular recognition domain; detecting the optical signal |
| 03/30/2006 | US20060068501 Apparatus and methods for steroid hormone testing |
| 03/30/2006 | US20060068500 Detecting yeast infections using a lateral flow assay |
| 03/30/2006 | US20060068499 Multi-array, multi-specific electrochemiluminescence testing |
| 03/30/2006 | US20060068466 Used in assays for the identification of new agents for anesthesia and analgesia |
| 03/30/2006 | US20060068460 Biochemical synthesis apparatus |
| 03/30/2006 | US20060068456 Methods for screening and identifying compounds |
| 03/30/2006 | US20060068453 Survivin, a protein that inhibits cellular apoptosis, and its modulation |
| 03/30/2006 | US20060068452 Differential protein expression patterns related to disease states |
| 03/30/2006 | US20060068451 Dimeric fluorescent polypeptides |
| 03/30/2006 | US20060068450 Microbead-filled microsystem and production method thereof |
| 03/30/2006 | US20060068449 N-terminal and C-terminal markers in nascent proteins |
| 03/30/2006 | US20060068448 isolated nucleic acid encoding a fungal antigen from Candida albicans; antiallergenic reaction to fungi in a vertebrate; and diagnosing a disease caused by fungi in a vertebrate; desensitization therapy for vaccines; immunosuppressants; insoluble cytoplasmic membrane proteins, free of cell wall |
| 03/30/2006 | US20060068447 Functionally organized, spatially patterned assembly polymer-microparticle composites including alternating current electric field-mediated assembly; systemic synthetic process to translate sequence of synthetic instructions into sequence of operations performed in homogenous fluid phase to form films |
| 03/30/2006 | US20060068446 Methods |